and specifi city of ASDAS cut-off values for disease activity states

Reviewing Disease Activity Indices in Spondyloarthritis From the Sex Perspective: A Systematic Review and Metaanalysis

JCM, Free Full-Text

Raising the Bar for Optimal Management of Axial Spondyloarthritis - European Medical Journal

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis - Trincianti - 2021 - Arthritis & Rheumatology - Wiley Online Library

Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis, Health and Quality of Life Outcomes

Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients - ScienceDirect

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain

Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis, Health and Quality of Life Outcomes

PDF) The Value of the Ankylosing Spondylitis Disease Activity Score (Asdas) in Evaluating Disease Activity in Patients with Axial Spondyloarthritis

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study, Arthritis Research & Therapy

Disease Control Data, Ankylosing Spondylitis

Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis - Martin Rudwaleit, Pedro M.

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO, Arthritis Research & Therapy

SciELO - Brasil - Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort Effectiveness and safety of secukinumab in ankylosing spondylitis and

The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology